ProShare Advisors LLC Raises Holdings in Elevance Health, Inc. $ELV

ProShare Advisors LLC increased its position in Elevance Health, Inc. (NYSE:ELV) by 5.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 42,253 shares of the company’s stock after acquiring an additional 2,025 shares during the quarter. ProShare Advisors LLC’s holdings in Elevance Health were worth $13,653,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Physician Wealth Advisors Inc. increased its stake in shares of Elevance Health by 331.6% in the third quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company’s stock worth $26,000 after purchasing an additional 63 shares in the last quarter. Activest Wealth Management lifted its stake in shares of Elevance Health by 66.7% during the 3rd quarter. Activest Wealth Management now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 34 shares in the last quarter. Vermillion & White Wealth Management Group LLC boosted its holdings in Elevance Health by 94.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after buying an additional 37 shares during the period. BOK Financial Private Wealth Inc. bought a new position in Elevance Health in the 2nd quarter worth approximately $32,000. Finally, Motco grew its stake in Elevance Health by 334.8% in the 3rd quarter. Motco now owns 100 shares of the company’s stock valued at $32,000 after buying an additional 77 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

ELV has been the topic of several recent research reports. Barclays dropped their target price on Elevance Health from $404.00 to $393.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $332.00 price objective on shares of Elevance Health in a research note on Thursday, January 29th. UBS Group set a $400.00 target price on Elevance Health in a research note on Thursday, January 29th. Sanford C. Bernstein reduced their target price on Elevance Health from $431.00 to $409.00 and set an “outperform” rating for the company in a report on Friday, January 30th. Finally, TD Cowen reiterated a “buy” rating on shares of Elevance Health in a research report on Wednesday, November 26th. Twelve analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $390.55.

Elevance Health Price Performance

Shares of NYSE ELV opened at $325.61 on Wednesday. The stock’s 50-day simple moving average is $351.86 and its two-hundred day simple moving average is $331.28. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75. The firm has a market capitalization of $71.87 billion, a P/E ratio of 12.96, a P/E/G ratio of 1.82 and a beta of 0.50. The company has a quick ratio of 1.56, a current ratio of 1.54 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last issued its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping the consensus estimate of $3.10 by $0.23. The company had revenue of $49.31 billion during the quarter, compared to analyst estimates of $49.52 billion. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.Elevance Health’s revenue was up 9.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.84 earnings per share. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, equities analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, March 10th. This is a positive change from Elevance Health’s previous quarterly dividend of $1.71. Elevance Health’s payout ratio is currently 27.23%.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.